Yumanity Therapeutics
Why Robinhood?
You can watch YMTX and buy or sell other stocks, ETFs, and their options commission-free!About YMTX
Kineta, Inc. is a clinical-stage biotechnology company, which engages in the development of immunotherapies for cancer patients. Its pipeline includes immuno-suppression: aVISTA mAb and exhausted T-cells: aCD27 agonist mAb.
YMTX Key Statistics
Stock Snapshot
The current Yumanity Therapeutics(YMTX) stock price is $2.55, with a market capitalization of 4.55M. The stock trades at a price-to-earnings (P/E) ratio of -0.50.
On 2026-07-03, Yumanity Therapeutics(YMTX) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 15.46K.
The stock's 52-week range extends from a low of $0.18 to a high of $1.15.
The stock's 52-week range extends from a low of $0.18 to a high of $1.15.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.